Allocation of patients to treatment in clinical trials.
暂无分享,去创建一个
[1] M. Hills,et al. The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.
[2] L. Freedman,et al. Allocation of patients to treatment groups in a controlled clinical study. , 1978, British Journal of Cancer.
[3] S. Carter,et al. Management of trials in the development of cancer chemotherapy. , 1978, British Journal of Cancer.
[4] T C Chalmers,et al. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. , 1977, The New England journal of medicine.
[5] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[6] L S Freedman,et al. On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. , 1976, Biometrics.
[7] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[8] M Zelen,et al. The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.
[9] P Armitage,et al. Statistical methods for the identification and use of prognostic factors , 1974, International journal of cancer.
[10] M. Zelen. Keynote address on biostatistics and data retrieval. , 1973, Cancer chemotherapy reports. Part 3.
[11] J B Block,et al. Controlled studies in clinical cancer research. , 1972, The New England journal of medicine.
[12] B. Efron. Forcing a sequential experiment to be balanced , 1971 .
[13] M. Zelen,et al. Play the Winner Rule and the Controlled Clinical Trial , 1969 .